Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -14.98%
March 31, 2026 -17.69%
December 31, 2025 -2.32%
September 30, 2025 -5.91%
June 30, 2025 -6.14%
March 31, 2025 -3.23%
December 31, 2024 -13.41%
September 30, 2024 -8.99%
June 30, 2024 -13.50%
March 31, 2024 -15.06%
December 31, 2023 -7.18%
September 30, 2023 -13.68%
June 30, 2023 -16.39%
March 31, 2023 -10.39%
December 31, 2022 -41.16%
September 30, 2022 -22.91%
June 30, 2022 -42.59%
March 31, 2022 -45.71%
December 31, 2021 -65.68%
September 30, 2021 -57.79%
June 30, 2021 -76.32%
March 31, 2021 -65.24%
December 31, 2020 -261.5%
September 30, 2020 -189.2%
June 30, 2020 -37.92%
Date Value
March 31, 2020 -58.85%
December 31, 2019 -18.43%
September 30, 2019 -35.33%
June 30, 2019 -35.69%
March 31, 2019 -27.18%
December 31, 2018 -37.45%
September 30, 2018 -53.30%
June 30, 2018 -31.83%
March 31, 2018 -17.79%
December 31, 2017 -357.5%
September 30, 2017 -31.77%
June 30, 2017 82.03%
March 31, 2017 -654.7%
December 31, 2016 -75.17%
September 30, 2016 -15.73%
June 30, 2016 -12.74%
March 31, 2016 -6.59%
December 31, 2015 -39.65%
September 30, 2015 2.89%
June 30, 2015 -7.57%
March 31, 2015 0.59%
December 31, 2014 -90.29%
September 30, 2014 -62.78%
June 30, 2014 -36.37%
March 31, 2014 -73.23%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Retrieve Medical Holdings, Inc. --
eXoZymes, Inc. --
HeartFlow, Inc. -24.57%
ACADIA Pharmaceuticals, Inc. 10.23%
Agenus, Inc. -1.64%